Children’s Hospital of Boston and Fate Therapeutics Sign IP Deal
The adult stem cell company Fate Therapeutics has announced a licensing agreement with Children’s Hospital of Boston.
May 20, 2009
The adult stem cell company Fate Therapeutics has announced a licensing agreement with Children’s Hospital of Boston.
The U.S. Patent and Trademark Office has awarded a patent to Pluristem Therapeutics for the invention of a novel method of expanding hemopoietic stem cells.
Scientists demonstrate that G-CSF can make you smarter.
Scientists demonstrate that adult stem cells from bone grafts extend cardiac transplant survival through immune modulation.
Scientists use human adult stem cells from umbilical cord blood to reverse liver failure in mice.
A top British events horse has bounced back to victory after receiving autologous adult stem cell therapy for a tendon injury.